Literature DB >> 7462634

Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding.

C Mold, C P Rodgers, R L Richards, C R Alving, H Gewurz.   

Abstract

We have previously presented a model for CRP-membrane interactions using liposomes composed of dimyristoyl phosphatidylcholine (DMPC), cholesterol (CHOL), stearylamine (SA), and galactosyl ceramide. We have shown that the interaction of cRP with these liposomes in the presence of human serum results in consumption of hemolytic C and membrane lysis. In the present paper we have directly examined the binding reaction between CRP and liposomes using radiolabeled CRP. We have found that this binding is more characteristic of CRP interactions with polycations than CRP interactions with phosphocholine- (PC) containing molecules. CRP binding to liposomes was dependent on the presence of SA in the membrane and could occur with dimyristoyl phosphatidylethanolamine in place of DMPC. The binding was not inhibited by ethylenediaminetetraacetate (EDTA) but could be inhibited by CaCl2, whereas CRP binding to PC-Sepharose was inhibited by EDTA and required CaCl2. We have further examined the effects of changes in membrane composition on CRP binding to liposomes. In liposomes with a limiting density of SA, we found increased CRP binding with changes in composition that would increase membrane fluidity. In most cases, the amount of CRP binding correlated with the amount of C activation observed previously. However, increasing the amount of CHOL in the membrane was found to increase C activation while decreasing CRP binding. These findings indicate that CRP binding to membranes and subsequent C activation can occur through cationic molecules as well as phospholipids.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462634

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Interaction of rabbit C-reactive protein with phospholipid monolayers studied by microfluorescence film balance with an externally applied electric field.

Authors:  L Z Mi; H W Wang; S F Sui
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

2.  Binding of human C-reactive protein to bacteria.

Authors:  C Mold; C P Rodgers; R L Kaplan; H Gewurz
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

3.  Effects of C-reactive protein and pentosan polysulphate on human complement activation.

Authors:  Andis Klegeris; Edith A Singh; Patrick L McGeer
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

4.  Calcium-dependent binding of rabbit C-reactive protein to supported lipid monolayers containing exposed phosphorylcholine group.

Authors:  S F Sui; Y T Sun; L Z Mi
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

5.  Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6.

Authors:  C Mold; K M Edwards; H Gewurz
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

Review 6.  Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities.

Authors:  Lawrence A Potempa; Wei Qiao Qiu; Ashley Stefanski; Ibraheem M Rajab
Journal:  Front Cardiovasc Med       Date:  2022-09-08

7.  Regulated export of a secretory protein from the ER of the hepatocyte: a specific binding site retaining C-reactive protein within the ER is downregulated during the acute phase response.

Authors:  S S Macintyre
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

8.  C-reactive protein is protective against Streptococcus pneumoniae infection in mice.

Authors:  C Mold; S Nakayama; T J Holzer; H Gewurz; T W Du Clos
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.